John SchroyerDecember 12, 2023
The FDA has 60 days to decide if the application will be accepted for review.
Tag: Multidisciplinary Association for Psychedelic Studies (MAPS)
John SchroyerDecember 12, 2023
StaffSeptember 14, 2023
The Daily Hit is a recap of the top financial news stories for Sept. 14, 2023. On the Site Canopy Growth Bows out of BioSteel Canopy Growth Corp. (TSX: WEED) (Nasdaq: CGC) will cease funding for its BioSteel Sports Nutrition unit. Following this, BioSteel has initiated proceedings under Canada’s Companies’ Creditors Arrangement Act. Read more […]
John SchroyerSeptember 14, 2023
MAPS is preparing to submit a formal new drug application to the FDA by end of year
Adam JacksonJuly 27, 2023
The company saw an 11% rise in client appointments during the quarter, signaling headway.
Get the latest cannabis news delivered right to your inbox
Unpack the industry with the daily cannabis newsletter for business leaders.